[1] |
KIRIAKIDOU M, CHING CL. Systemic lupus erythematosus[J]. Ann Intern Med, 2020, 172(11): ITC81-ITC96. DOI: 10.7326/AITC202006020.
|
[2] |
Chinese Rheumatology Association, National Clinical Research Center for Dermatologic and Immunologic Diseases, Chinese Systemic Lupus Erythematosus Treatment and Research Group. 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus[J]. Chin J Intern Med, 2020, 59(3): 172-185. DOI: 10.3760/cma.j.issn.0578-1426.2020.03.002.
中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3): 172-185. DOI: 10.3760/cma.j.issn.0578-1426.2020.03.002.
|
[3] |
GALIÈ N, CHANNICK RN, FRANTZ RP, et al. Risk stratification and medical therapy of pulmonary arterial hypertension[J]. Eur Respir J, 2019, 53(1): 1801889. DOI: 10.1183/13993003.01889-2018.
|
[4] |
SONG ZR, ZHANG WR, CAO X, et al. Literature case analysis of liver injury caused by bosentan[J]. ADRJ, 2020, 22(12): 683-688. DOI: 10.3760/cma.j.cn114015-20200511-00520.
宋兆芮, 张文锐, 曹雪, 等. 波生坦致肝损伤文献病例分析[J]. 药物不良反应杂志, 2020, 22(12): 683-688. DOI: 10.3760/cma.j.cn114015-20200511-00520.
|
[5] |
WEI A, GU Z, LI J, et al. Clinical adverse effects of endothelin receptor antagonists: Insights from the meta-analysis of 4894 patients from 24 randomized double-blind placebo-controlled clinical trials[J]. J Am Heart Assoc, 2016, 5(11): e003896. DOI: 10.1161/JAHA.116.003896.
|
[6] |
GALIÈ N, HUMBERT M, VACHIERY JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)[J]. Eur Respir J, 2015, 46(4): 903-975. DOI: 10.1183/13993003.01032-2015.
|
[7] |
HACHULLA E, JAIS X, CINQUETTI G, et al. Pulmonary arterial hypertension associated with systemic lupus erythematosus: Results from the french pulmonary hypertension registry[J]. Chest, 2018, 153(1): 143-151. DOI: 10.1016/j.chest.2017.08.014.
|
[8] |
WANG MJ, YANG YX, JI QW. Connective tissue disease in pulmonary arterial hypertension[J]. Chin J New Clin Med, 2020, 13(9): 874-877. DOI: 10.3969/j.issn.1674-3806.2020.09.06.
王孟杰, 杨映霞, 吉庆伟. 肺动脉高压之结缔组织疾病[J]. 中国临床新医学, 2020, 13(9): 874-877. DOI: 10.3969/j.issn.1674-3806.2020.09.06.
|
[9] |
CHEN HA, HSU TC, YANG SC, et al. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: A nationwide cohort study[J]. Arthritis Res Ther, 2019, 21(1): 82. DOI: 10.1186/s13075-019-1868-0.
|
[10] |
ARINGER M, COSTENBADER K, DAIKH D, et al. 2019 European league against Rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus[J]. Arthritis Rheumatol, 2019, 71(9): 1400-1412. DOI: 10.1002/art.40930.
|
[11] |
GEBRESELASSIE A, ADULI F, HOWELL CD. Rheumatologic diseases and the liver[J]. Clin Liver Dis, 2019, 23(2): 247-261. DOI: 10.1016/j.cld.2018.12.007.
|
[12] |
TAKAHASHI A, ABE K, SAITO R, et al. Liver dysfunction in patients with systemic lupus erythematosus[J]. Intern Med, 2013, 52(13): 1461-1465. DOI: 10.2169/internalmedicine.52.9458.
|
[13] |
AFZAL W, HAGHI M, HASNI SA, et al. Lupus hepatitis, more than just elevated liver enzymes[J]. Scand J Rheumatol, 2020, 49(6): 427-433. DOI: 10.1080/03009742.2020.1744712.
|
[14] |
MIELI-VERGANI G, VERGANI D, CZAJA AJ, et al. Autoimmune hepatitis[J]. Nat Rev Dis Primers, 2018, 4: 18017. DOI: 10.1038/nrdp.2018.17.
|
[15] |
ADIGA A, NUGENT K. Lupus hepatitis and autoimmune hepatitis (lupoid hepatitis)[J]. Am J Med Sci, 2017, 353(4): 329-335. DOI: 10.1016/j.amjms.2016.10.014.
|
[16] |
ZHANG MY, HAN L, SUN Y, et al. Research advances in clinical treatment of adult autoimmune hepatitis[J]. J Clin Hepatol, 2021, 37(6): 1459-1465. DOI: 10.3969/j.issn.1001-5256.2021.06.050.
张明月, 韩琳, 孙颖, 等. 成人自身免疫性肝炎临床治疗进展[J]. 临床肝胆病杂志, 2021, 37(6): 1459-1465. DOI: 10.3969/j.issn.1001-5256.2021.06.050.
|
[17] |
ALVES S C, FASANO S, ISENBERG DA. Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review[J]. Lupus, 2016, 25(14): 1509-1519. DOI: 10.1177/0961203316655210.
|
[18] |
EFE C, PURNAK T, OZASLAN E. Systemic lupus erythematosus and autoimmune hepatitis[J]. Rheumatol Int, 2011, 31(3): 419. DOI: 10.1007/s00296-010-1581-4.
|
[19] |
XU Y. A comparison of autoimmune hepatitis and systemic lupus erythematosus-associated hepatitis[J]. Chin J Gastroenterol Hepatol, 2009, 18(4): 366-368. DOI: 10.3969/j.issn.1006-5709.2009.04.027.
徐芸. 自身免疫性肝炎与系统性红斑狼疮性肝损伤临床特征对比[J]. 胃肠病学和肝病学杂志, 2009, 18(4): 366-368. DOI: 10.3969/j.issn.1006-5709.2009.04.027.
|
[20] |
National Data Center for Rheumatic Disease, Chinese Research and Cooperation Group for Systemic Lupus Erythe. Diagnosis and treatment consensus on systemic lupus erythematosus associated pulmonary hypertension in Chinese adults[J]. Chin J Intern Med, 2015, 54(1): 81-86. DOI: 10.3760/cma.j.issn.0578-1426.2015.01.024.
国家风湿病数据中心, 中国系统性红斑狼疮研究协作组. 中国成人系统性红斑狼疮相关肺动脉高压诊治共识[J]. 中华内科杂志, 2015, 54(1): 81-86. DOI: 10.3760/cma.j.issn.0578-1426.2015.01.024.
|
[21] |
KAESTNER M, SCHRANZ D, WARNECKE G, et al. Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK[J]. Heart, 2016, 102(Suppl 2): i57-i66. DOI: 10.1136/heartjnl-2015-307774.
|